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1Introduction
1.1 Motivation
Congenital Long-QT Syndrome (LQTS) is a genetic disorder affecting the repolarization
of the heart. Genes that encode for the various cardiac ion channels or regulatory proteins
of these channels are mutated, which tends to prolong the duration of the ventricular
action potential (APD). Thus, it leads to a propensity for ventricular arrhythmias, in-
creasing risk of unexpected cardiac arrests. It affects up to 1 out of 2500 people and it’s
a common cause of sudden cardiac death among children and young population.
Currently, LQTS is classified according to 12 types of ion channel mutation (LQT1-12)
but the first three, LQT1-3, are the most prevalent and most studied. LQT1 occurs in
30-35%, LQT2 in 25-30%, LQT3 in 5-10%, LQT4 in 1-2%, and LQT5 in 1% of cases.
LQT6-12 are all rare.
Despite the significant increase regarding the understanding of this heart disease in the
past years, some gaps related to the diagnosis and sub-typing methods are still in need
to be filled. Genetic testing can be used to identify the responsible genes in patients
with known disease but, as with all genetic tests, there are some important limitations to
LQTS genetic testing. First of all, although since 2004 advances have enabled LQTS ge-
netic testing to be commercially available (and thus the initially very high costs have been
decreased), they’re still not affordable for a significant part of the population. Besides the
financial aspect, it is essential to be aware of the fact that the currently available genetic
test will not be able to identify the LQTS-causing mutation in 100% of the patients (the
error percentage is hovered around 25%). New technologies are continually being devel-
oped to better identify the still unknown mutations and, as these defects are characterized
and validated, they must be incorporated into the commercially available testing. There-
fore, it is of great importance to investigate and to develop alternative methods, in order
to provide higher accuracy regarding the diagnosis and sub-typing of LQTS.
2 Chapter 1. Introduction
The experimental and clinical possibilities for studying cardiac arrhythmias in human ven-
tricular myocardium are very limited. Animal hearts used for empirical studies may differ
significantly from human hearts (heart size, heart rate, action potential shape, duration
and restitution, vulnerability to arrhythmias, etc.) and cardiac arrhythmias are three-
dimensional phenomena whereas experimental observations are still largely constrained
to surface recordings. For these reasons, over the last 50 years observational cardiac elec-
trophysiology has been increasingly complemented by computational models of membrane
excitability. The mentioned models, combined with computer simulations can be used to
test and generate hypotheses that are difficult to address experimentally.
1.2 Objectives and Outline
The objective of this work is to investigate alternative methods to distinguish between the
first three types of the Long-QT syndrome by looking for differences in simulated Body
Surface Potential Maps (BSMP). Research in this area would provide a better understand-
ing of the voltage distribution affected by the mutations. A model of human ventricular
myocytes was adapted to represent the behavior of the mutated channels and BSMP were
simulated including the subtypes.
Chapter two illustrates the heart structure both microscopically and macroscopically, giv-
ing a short introduction on cardiac anatomy and electrophysiology in order to provide the
basics to get a better understanding of the theory behind this project.
The Long-QT syndrome is described in chapter three. After an overview, channel kinetics
and mutations behind this pathology are detailed for each of the studied subtypes. Cur-
rent diagnosis methods are also explained and disadvantages are exposed.
The methods and procedures followed in this study are explained in depth in chapter four.
Starting with electrophysiological modeling until BSPM simulation all the techniques and
processes that were carried out are described together with the necessary mathematical
background. That leads to chapter five, where all the obtained results are displayed.
Finally, chapter 6 provides a summary of the project and chapter 7 describes the limita-
tions of this work and points out perspectives for future investigations.
2Cardiac Anatomy and Electrophysiology
2.1 Cardiac Anatomy
The human heart is a muscular organ that provides a continuous blood circulation through
the cardiovascular system, which is designed to transport oxygen and nutrients to the
cells and remove carbon dioxide and metabolic waste products from the body. It is lo-
cated obliquely in the chest behind the body of the sternum and adjoining parts of the rib
cartilages, and projects farther into the left than into the right half of the thoracic cavity.
The human heart is about the size of a fist and its weight varies from 230 to 340 grams,
depending on the gender, being female hearts usually less heavy than male hearts.
Fig. 2.1. Schematic description of the heart anatomy. [1]
4 Chapter 2. Cardiac Anatomy and Electrophysiology
A thick wall of muscle denominated septum separates the right and left halves of the
organ and those are at the same time subdivided into 2 cavities each. Thus, the heart
is divided in 4 chambers: the two upper ones are called right and left atria, whereas the
two lower chambers are called right and left ventricles. The right ventricle and the right
atrium are separated by the tricuspid valve, allowing the atrium to fill the ventricle with
blood collected by the Vena cava superior and the Vena cava inferior. Similarly, the left
ventricle and the left atrium are separated by the bicuspid valve and the blood has to to
pass the aortic valve to get into the body circle via the aorta. The function of the right
side of the heart is to collect de-oxygenated blood, in the right atrium, from the body
and pump it, via the right ventricle, into the lungs so that carbon dioxide can be dropped
off and oxygen picked up. The left side collects oxygenated blood from the lungs into the
left atrium. From the left atrium the blood moves to the left ventricle which pumps it
out to the body via the aorta by contractions. These contractions occur regularly and
at the rate of about seventy per minute. Each wave of contraction or period of activity
is followed by a period of rest, the two periods constituting what is known as a cardiac
cycle. Each cardiac cycle consists of three phases, which succeed each other as follows:
a short simultaneous contraction of both atria, termed the atrial systole, followed, af-
ter a slight delay, by a simultaneous but more prolonged contraction of both ventricles
named the ventricular systole, and a period of rest during which the whole heart is relaxed.
The muscular wall of the heart consists of three different layers: the epicardium, the
protective inner layer, underlies the myocardium, the actual muscle, which is followed by
the outer layer called epicardium. The heart is surrounded by a small amount of fluid
enclosed by a fibrous sac: the pericardium.
2.2 Cell Physiology
2.2.1 The Cell Membrane
The cell membrane of a cardiomyocyte is also called sarcolemma and it consists of a
phospholipid bilayer. The bilayer structure is attributable to the special properties of the
lipid molecules, which cause them to assemble spontaneously, due to a polar head group
and two hydrophobic hydrocarbon tails [2]. The main function provided by the membrane
is being a barrier for diffusion. Unlike other lipid bilayers, proteins such as receptors,
pumps and channels are also contained in the sarcolemma, essential fact to the contractile
process of the myocyte [3]. The ionic concentration is established by the flow of sodium
(Na+), potassium (K+), calcium (Ca2+), and chloride (Cl−) ions through the bilayer and
these flows are controlled by those proteins. Figure 2.2 depicts a schematic description of
the membrane including channels, pumps and receptors.
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Fig. 2.2. Schematic description of the cell membrane including ionic exchangers and pumps. Different
concentrations of potassium (blue circles) and sodium (red circles) in the intra- and extracellular space lead
to concentration gradients across the cell membrane (thin arrows). The transmembrane proteins describing
K+ channel and Na+ -K+-pump are represented in yellow. Adapted from [4]
2.2.1.1 Ion Channels
As mentioned, ion channels are proteins that the sarcolemma contains. They regulate
the flow of ions through the membrane controlling its selective permeability, due to the
fact that they are specific regarding the different ion types. Various subunits construct
these ion channels and these subunits are expressed by several genes. The α subunit is
in charge of forming the channel itself, whereas the β and γ subunits modulate its function.
The mechanism of controlling the ionic flow is called gating. The ionic channels have dif-
ferent configurations: open, closed or inactivated, being the open state the only one in
which ions are conducted. Different types of stimuli regulate the gating. In the so called
voltage gated channels, voltage sensors sense certain changes in the transmembrane volt-
age provoking the switching of states. In other cases, specific ligands, namely acetylcholine
(ACh) or adenosine triphosphate (ATP) have the ability to manage this feature, hence
their name: ligand gated channels.
2.2.1.2 Pumps
Energy transformation also leads to ionic transportation through the cell. Ion pumps or
ATPases perform ATP or ADP hydrolysis and consequently obtain the energy needed for
the process. In the sarcolemma the Na+ -K+ - and the Ca2+ -pump are the main contrib-
utors for the active transport. The Na+, K+ ATPase is pumping three Na+ ions out of the
cell and at the same time two K+ ions into it. This conducts to an ion concentration gra-
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Fig. 2.3. Schematic representation of several ionic channels in the sarcolemma and with different config-
urations. From [5]
dient between intra- and extracellular space, which mantains the resting transmembrane
voltage and, therefore, the excitability of the cell.
2.2.1.3 Exchangers
Ion exchangers allow transport against the gradient but don’t require the use of external
energy. They use the passive transfer of an ion type as a carrier by coupling the desired
substance. If the substance is transported in the same direction as the forcing ion type, the
transport mechanism is termed symport, otherwise it is named antiport. One of the most
important exchangers when it comes to cardiac electrophysiology is the Na+-Ca2+. This
exchanger regulates the distribution of Ca2+ in the inner and outer fluid. This distribution
is imperative for the cardiac contraction.
2.2.1.4 Gap Junctions
Neighboring cells present coupling regions called intercalated discs. At these regions, low
resistance pores are formed by proteins of adjacent cells: the so called gap-junctions [6].
These junctions allow for direct transport of substances between cells i.e they are not
selective to specific ions and metabolites. This leads to a rapid propagation of the action
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potential.
Gap junctions consist of connexons, which are formed by six protein subunits called con-
nexins. Different types of connexins exist in the cardiac tissue, each of them present-
ing different values of unitary conductances. Moreover, the distribution of gap junctions
throughout the heart is not homogeneous.
Fig. 2.4. Schematic representation of gap junctions. a) Six connexins form the connexon and two con-
nexons are coupled to build the gap junction. b) Molecular organization of a gap junction.’E’ extracellular
gap,’M’ membrane area, ’C’ cytoplasmic space. From [7] and [8]
2.2.2 Ion Diffusion
Diffusion of ion is the most important of the so called passive transport mechanisms.
No energy is required for this process, hence its classification as passive. When different
molecule concentrations exist in different locations, molecules will move from the most
to the least populated zone, compensating the original gradient. Fick’s diffusion law de-
scribes the diffusion rate in a selective-permeable membrane:
Jdiff = AD
∆C
∆x
(2.1)
Where A is the area where the diffusion takes place, D the diffusion coefficient according
to the Stokes-Einstein equation, ∆ C the concentration difference between two zones, and
∆ x the thickness of the membrane. Therefore, the thinner the membrane is, the most
effective the transport via diffusion.
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If the transported molecules are electrically charged, i.e ions, the electrical gradient is
changed when the particles pass through the membrane, creating a potential difference
which leads to an electrical driving force affecting the ions (see equation 2.2). This force
can be calculated given a potential difference U and the valence zx of the ion X.
Fm = zx
U
∆x
(2.2)
The total flux is the sum of the flux caused by diffusion and the flux caused by electrical
forces. When it equals zero, an electrochemical equilibrium is reached and, in this situation
a concentration difference of ion type X exist between intra- and extramembrane making
it possible to calculate the equilibrium voltage via the Nernst equation:
Ex =
−RT
zxF
ln
cin,x
cout,x
(2.3)
with F being the Faraday constant, and cout,x and cin,x being the extra- and intracellular
concentrations, respectively.
2.2.3 Electrical Properties of the Cell Membrane
2.2.3.1 Resting Voltage
As previously described, the electrical gradient is changed when the particles pass through
the membrane, creating a potential difference between intra- and extracellular locations.
This voltage is called transmembrane voltage. Despite the fact that cells can have different
transmembrane voltages, only the equilibrium voltage is called resting voltage. This resting
voltage can be obtained by the Goldman-Hodgkin-Katz equation, which is an extension
of the Nerst equation to take into account different ions:
Vm =
−RT
zxF
ln
PK,cin,KPNa,cin,NaPCl,cin,Cl
PK,cout,KPNa,cout,NaPCl,cout,Cl
(2.4)
PK,cK , PNa,cK and PCl,cK express the permeability for potassium, sodium and chlorine
ions respectively. A more exhaustive description of the transmembrane voltage is achieved
by including Ca2+ and the charge transport resulting from the exchangers in equation 2.4.
2.2.3.2 Action Potential
The action potential (AP) is the process that is initiated when the transmembrane voltage
elevates due to an external stimuli and it is fundamental for the transmission of informa-
tion through electrically active cells. When the transmembrane voltage exceeds a certain
threshold, usually around -40 or -60 mV, the Na+ channels open, causing a fast upstroke
in the action potential. This opening leads to an inflow of INa, resulting on a rapid de-
polarization (Phase 1 in figure 2.5) where the voltage moves towards the Na equilibrium
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potential. Around 10ms after, the transient outward potassium current, Ito, makes the
voltage decrease to near 0 mV and leads to an early rapid repolarization. This is followed
by the opening of calcium channels acting against repolarization forces, which causes the
voltage to stabilize and remain nearly constant; the Plateau phase (Phase 2). The calcium
influx is responsible for initiating the contraction of the myocyte. Finally, delayed volt-
age dependent potassium channels or ”delayed rectifiers” release IKs, IKr and IKur (slow,
rapid and ultra rapid delayed potassium currents respectively) which are responsible for
the rapid repolarization (Phase 3). The return to resting voltage is achieved thanks to the
inward rectifier K+ current IK1 (Phase 4).
Fig. 2.5. The principal flux of the various ionic currents and the resulting action potential of a cardiac
myocyte[9]
2.2.3.3 Refractory Period
After depolarization, further APs are unachievable due to Na+ channel inactivation. The
period of time in which those channels remain inactivated is called refractory period, and
it has two different phases: absolute (when no matter how strong the stimulus is, the
channels are completely inactive) and, immediately after, relative (new depolarization is
generally possible, but with lower magnitude and a shorter duration). The refractoriness
of a cell is dependent on the action potential duration (APD) since the refractory period
ends when the cell membrane reaches the equilibrium voltage.
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Fig. 2.6. The refractory period and its phases: absolute and relative refractoriness. During the first,
no action potential is initiated, whereas during the second new depolarization is possible but with lower
magnitude and shorter duration. Adapted from [4]
2.2.4 Electrical Conduction System
The propagation of the cardiac excitation is vital for the correct pumping of the heart.
The atria are the first to depolarize, and the excitation reaches the complete ventricular
muscle around 120ms after. The process can be seen in figure 2.7.
The sinus node, a region of the right atrium muscular tissue, is the origin of the excitation
and the pacemaker. Other potential pacemakers exist in the human heart but they only
have that function if the sinus node fails to perform its task. Once the excitation starts,
it travels through the crista terminalis and the pectinate muscles, allowing with this the
depolarization of the right atrial myocardium. It also continues into the Bachmann bundle
to the left atrium, until the whole atrium is activated. The impulse continues throughout
the atrioventricular node (AV), which is the only point of electrical contact between atria
and ventricles. Here, the excitation suffers a delay of approximately 100ms in order to
synchronize the temporal sequence. This delay is of great importance, since it allows a
complete ventricular filling.
After the delay in the AV, the stimulus is conducted to the Purkinje fibers through the
His and the Tawara bundles, leading then to a complete depolarization of the ventricular
tissue.
2.3. The Electrocardiogram 11
Fig. 2.7. The electrical conduction system of the heart. From [10]
2.3 The Electrocardiogram
To allow an understanding of the conduction system, an interpretation of the electrical
activity is recorded via electrodes attached to the skin and located across the thorax [11].
That recording is called Electrocardiogram (ECD).
A regular ECG ”drawing” consists of a P wave, a QRS complex, a T wave and a U wave,
although only in the 50 to 75% of ECGs is this U wave visible[12]. The P wave represents
the depolarization of the atrial myocardium, whereas the QRS complex reflects the rapid
depolarization of the right and left ventricles. The higher ventricular mass is what causes
the QRS complex to be significantly higher than the P wave. The T wave stands for the
ventricular repolarization and the U wave is believed to be caused by the repolarization
of the interventricular septum [13].
2.3.1 The T Wave
As we mentioned above, the T wave represents ventricular repolarization. In humans, the
T wave usually appears to be concordant with the QRS complex and it is commonly
accepted that dispersion of repolarization (DOR) is responsible for this concordance [15].
For this reason it is important to investigate the impact of the DOR in the T wave so
that we get a better understanding of its morphology. In this work we intend to do so, as
explained in section 4.3.
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Fig. 2.8. The ECG and its different waves and segments. From [14]
3Long-QT Syndrome
3.1 Overview
Generally speaking, the Long-QT Syndrome is a genetic disorder affecting the repolariza-
tion of the heart, and it has an autosomal-dominant inheritance pattern. [16]. As its self-
explanatory name indicates, the Long-QT Syndrome is characterized by a prolongation
of the QT time in the ECG. Differences can also be noticed among different parameters
such as shape or duration of the T-wave [17]. The QT interval indicates the duration of
ventricular depolarization and repolarization, which is caused by transmembrane flow of
ions. Measuring this time, though, is harder than what one would expect. For instance,
the interval varies with the heart rate [18] and it is difficult to determine what to measure
due to the fact that the T-wave changes among individuals. A way to reach a standarized
criterium is the so called corrected QT time or QTC , which is adjusted to the heart rate.
Nevertheless, in some cases, people suffering from the Long-QT syndrome appear to have
a normal QT interval, hence the suggestion to call it congenital repolarization syndrome
[18].
People suffering from this pathology show mutated genes which encode either ion-channels
or proteins in charge of modifying the function of these channels. These channels are re-
sponsible for regulating the flow of sodium, calcium and potassium in cardiac myocytes
and, when mutated, cause changes in the mentioned flows [19]. For example, if the outward
flow of the potassium current during the 3rd stage of the action potential is decreased or
there is late entry of sodium ions in the myocytes due to a defect in the corresponding
channels, the APD is enlarged and this leads to a QT prolongation compared to the phys-
iological case [20].
Although the frequency of Long-QT syndrome is still not certainly known, it possibly
ranges from 1:2000 to 1:5000 [21] [22] and research on the topic is of great importance due
to the fact that the Long-QT Syndrome can lead to sudden death caused by ventricular
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fibrillation. Episodes may be provoked by various stimuli, depending on the subtype of
the condition [17].
3.2 Subtypes
LQTS can arise from mutation of one of several genes [20]. Mutations in the alpha-
subunit-regulating genes of three channels are the most common genetic causes for LQTS.
Those mentioned three channels are: the slowly activating potassium repolarization chan-
nel (KCNQ1; LQT1); the rapidly activating potassium repolarization channel (KCNH2;
LQT2) and the sodium channel (SCN5A; LQT3). In the first two cases the IKs and IKr
appear reduced, whereas the third one shows an increase in late INa flow. In addition,
LQTS has been identified in patients with mutations involving the auxiliary beta-subunits
of KCNQ1 (minK; LQT5) and of KCNH2 (MiRP1; LQT6). Furthermore, until this day
a high number of mutations in channel and proteins have been found and registered, fact
that has led to a classification of LQTS in at least ten subtypes. However, it’s imperative
to keep in mind that mutations in these same channels may cause other disease pheno-
types [17].
As mentioned, LQTS can be classified in at least 10 subtypes, depending on the mutated
gene or the mutation type. Nevertheless this work will focus on Long-QT Syndromes 1, 2
and 3 for being the most common. In these subtypes, the genes encoding the subunits of
the proteins forming the currents IKs, IKr, and INa are mutant, respectively.
Table 3.1. Brief description of the main subtypes of the Long-QT Syndrome. Adapted from [19]
Subtype Frequency Gene Ion Channel Deffect
LQT-1 30-35% KCNQ1 alpha subunit of slowly activating delayed
rectifier K+ channel
LQT-2 25-30% HERG alpha subunit of rapidly activating delayed
rectifier K+ channel
LQT-3 5-10% SCN5A alpha subunit of voltage gated Na+ channel
LQT-4 1-2% ANKB Ankyrin B adaptor protein that anchors
Na+-K+ ATPaseand Na+/Ca2+ exchanger
LQT-5 1% Mink
(KCNE1)
beta subunit of slowly activating delayed
rectifier K+ channel
3.2.1 Long-QT Type 1
LQT1 is the most common type of Long-QT syndrome, occurring in a 30 percent of all
cases approximately. It is caused by mutations in the α - subunit of the Kv7.1 channel
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protein. Kv7.1 is a potassium channel protein coded for by the gene KCNQ1, which has
been isolated to chromosome 11p15.5 [23]. The channel is responsible for the slowly de-
activating delayed rectifier potassium current IKs. Mutations in this gene mainly cause
a decrease on the flow of IKs which leads to transmural dispersion of repolarization in
the left ventricular wall [17]. When dysfunctional IKs, outstanding ICa,L causes a delayed
repolarization. The APD of all cell types is enlarged, due to the fact that IKr is nearly
homogeneously distributed throughout the heart [6]
The function of KCNQ1 was defined thanks to studies performed by Sanguinetti et al.
[24] and Barhanin et al. [25]. They used Chinese hamster ovary cells and COS cells to find
that cotransfection with KCNE1 was required to form the IKs current. Melman et al. [26]
demonstrated that all KCNE-binding sites of Kv7.1 are required for proper regulation by
the accessory subunit. [20].
3.2.2 Long-QT Type 2
LQT2 appears less frequently than LQT1, being the second most common among all the
Long-QT Syndromes. It is found in approximately 25 percent of the cases. It also affects
the potassium channel but the affected gene is the so called human ether-a-go-go related
gene (hERG), which is responsible for the potassium rapid rectifying current, IKr, whereas
the affected current in LQT1 was IKs. As well as IKs, IKr influences the termination of
the cardiac action potential and its flow keeps the heart from early after depolarizations.
The LQT2 related mutations reduce the current, thus K ions find it more difficult to pass
through. The remaining repolarizing current IKs is heterogeneously distributed, hence the
more significant prolongation of the APD in M cells, rather than Endo and Epi cells.
3.2.3 Long-QT Type 3
Although less common than the first two types, LQT3 is more lethal than the above de-
scribed. Unlike for LQT1 and LQT2 the affected channel here is not a potassium channel
but a sodium one. The current named INa flows through the channel and is responsible
for the fast upstroke of the AP. A defect in gene SCN5A keeps the channel from re-
maining inactivated, causing late flow of INa, fact that does not happen in physiological
cases. Therefore, APD is enlarged. The effect is noticeable in all cell types, although more
significant in M cells, due to the already longer Plateau phase.
3.3 Diagnosis
Cardiologists usually receive potential Long-QT patients after they experience a car-
diac arrhythmia, syncope, an aborted cardiac arrest, episode of palpitation, or sudden
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death/cardiac arrest in a relative. Usually, a differential diagnosis is performed which in-
cludes hypertrophic cardiomyopathy (HCM), arrhythmogenic right ventricular cardiomy-
opathy/dysplasia (ARVC/D), long QT syndrome, drug-induced QT prolongation, Bru-
gada syndrome (BS), and some other even less frequent causes of sudden death in young
age groups [16].
A detailed family history is imperative since it looks for a history of syncope or sudden
unexplained death not only in first-degree relatives but also in more remote relatives in
the family [27]. ECGs are obtained not only from the patient but from direct relatives as
well, with the purpose of identifying enlarged QT intervals or irregular T-wave shapes.
As mentioned, not all patients suffering from Long-QT have a long QT interval on an
ECG; the QT interval may change from time to time [28]. In patients with normal QTC ,
abnormal T-wave morphology may provide useful information, hence the importance to
perform multiple ECGs and careful evaluations of T-wave morphology in these ECGs [16].
Physical exams looking for signs of conditions that may lower blood levels of potassium or
sodium are also performed. These conditions include the eating disorders anorexia nervosa
and bulimia, excess vomiting or diarrhea, and certain thyroid disorders [28].
3.3.1 Long-QT Score
In 1993, Schwartz and colleagues [29] published a diagnosis score which proposes that if a
value of at least 4 is reached, the probability of Long-QT diagnosis is high whereas in the
case of score values of 2 to 3, the plausibility of diagnosis is lower. This method is shown
in figure 3.1. What’s remarkable about this score is the fact that it’s not only based on
the QT interval but it also relies on findings frequently seen in Long-QT patients, such as
T-wave alternans, T-wave notches or bradycardia [16].
3.3.2 Genetic Testing
The main point where genetic testing is useful is family screening. Identifying the mutation
in a proband provides an opportunity to conduct genotyping of family members who
frequently cannot be diagnosed just based on ECG data [27]. Besides, the clinical course
is different by genotype, [30], [31] and the treatment differs depending on the Long-QT
subtype, thus genetic testing is an important diagnosis procedure. However, this method
is limited by its excessively high cost and its lack of accuracy; about one-third of LQTS
cases cannot be detected by these tests and as many as one-third of the people who test
positive for LQTS don’t have any signs or symptoms of the disorder [32].
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Fig. 3.1. Long-QT diagnosing score. Taken from [27]

4Methods
4.1 Data Acquisition
4.1.1 Voltage Clamp Technique
The voltage clamp technique is an electrophysiological method for measuring ion cur-
rents across the membrane of excitable cells while holding the membrane voltage at a set
level. The voltage clamp allows the membrane voltage to be manipulated independently
of the ionic currents, allowing the current-voltage relationships of membrane channels to
be studied.
This procedure was first introduced by Kenneth Cole and George Marmount in 1949 and
after experiments with the voltage clamp, Alan Hodgkin and Andrew Huxley outlined the
ionic causes of the action potential in 1952.
The voltage clamp apparatus consists of a feedback amplifier, a voltage amplifier, and an
ammeter. The voltage amplifier is connected to a voltage electrode inserted inside the cell,
and to the feedback amplifier. The feedback amplifier is connected to a current electrode.
Finally, a ground electrode completes the feedback and voltage circuits through an am-
meter to ground.
During the performance of the technique, the researcher sets the holding voltage, called
command voltage Vc, and the voltage amplifier measures Vm. A comparator determines
the difference between Vc and Vm and generates a difference signal if both voltages are not
equal. This signal is sent to the feedback amplifier, which sends an output to the current
electrode and current is injected into the cell in order to make Vc equal to Vm. Thus, the
clamp circuit produces a current equal and opposite to the ionic currents flowing across
the cell membrane, which can easily be measured using the ammeter.
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Figure 4.1 shows an example of a voltage clamp protocol. The membrane voltage is stepped
from resting potential to different voltages which are held (holding voltage) a certain
amount of time that can vary according to the experiment. During this time, current
flowing across the membrane is measured, leading to the curves in the image. After the
step, the voltage is set back to resting voltage causing what is called tail current to, finally,
go back to resting voltage until no current flows.
Fig. 4.1. Example of a voltage clamp protocol with both the applied voltages and the measured currents.
This data was provided by the university hospital in Heidelberg and will be used for the research in this
paper.
4.1.2 Patch Clamp Technique
The patch clamp technique is a refinement of the voltage clamp method and it allows
recordings in single ion channel currents. It was first used by Neher and Sakmann (1976)
to resolve currents through single acetylcholine-activated channels in cell-attached patches
of membrane of frog skeletal muscle [33]. The principle of the method is to electrically
isolate a patch of membrane from the external solution and to record current flowing into
the patch. That patch contains just one or a few ion channel molecules.
A fire-polished glass pipette, previously filled with a suitable electrolyte solution, is pressed
against the surface of a cell and bonds with the cell membrane by a negative pressure
present at the tip. A seal whose electrical resistance is more than 10 Gigaohms forms
between the edge of the pipette and the patch, and the currents can be recorded. This
high seal resistance is needed for two reasons. First, the higher the seal resistance, the
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more complete is the electrical isolation of the membrane patch. Second, a high seal resis-
tance reduces the current noise of the recording, permitting good time resolution of single
channel currents.
Fig. 4.2. Patch Clamp Technique with miscellaneous configurations. Modified from [34]
Depending on the researchers goals, different variations of the patch clamp technique can
be considered. The above explained is the Cell-attached, where the electrode is sealed to
the patch of membrane, and the cell remains intact. If the investigator wishes to manip-
ulate the environment at the intracellular surface of ion channels, after the gigaseal is
formed, the micropipette will be quickly withdrawn from the cell, thus ripping the patch
of membrane off the cell. This is called Inside-Out patch. It is also possible to perform
whole-cell recordings if desired, and that is achieved by the Whole-Cell-Recording tech-
nique. In this case, the electrode is left in place on the cell, but more suction is applied
to rupture the membrane patch, therefore access to the intracellular space of the cell is
provided. After application of the Whole-Cell-Recording, the electrode can be slowly with-
drawn from the patch. If the electrode is pulled away far enough, the patch will detach
from the cell and will reform as a convex membrane at the tip of the pipette. That allows
the experimenter to examine the properties of an ion channel when it is isolated from
the cell and exposed to different solutions on the extracellular surface of the membrane.
Another two variations that can be applied are the Perforated-Patch and the Loose-Patch,
although they’re not as widely used as the previous ones.
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4.1.3 Gathered Data
As described in section 3.2, mutations causing LQT-1 and LQT-2 are responsible for
modified kinetics in the potassium ion channels, and, more specifically, they affect the
slow and rapid delayed currents. For this work, data was gathered from different sources.
4.1.3.1 LQT-1 Data
The Department of Internal Medicine, University Hospital in Heidelberg gathered the
data regarding Long-QT Syndrome 1. LQT-1 related mutation S277L was induced in the
KCNQ1 gene and IKs was recorded for both the wild type and the coexpression of the
wild type and the mutation, using the techniques described in 4.1. The exact conditions
in which the measurements were performed can be found in [35]. Note how IKs is indeed
reduced for the coexpression case.
Fig. 4.3. Current-Voltage graphs for IKs Wild Type (left) and coexpressed S277L mutation (right) char-
acteristics. Different colors express different voltage clamp steps.
Fig. 4.4. Voltage clamp protocol for LQT-1 measurements. Voltage is applied in 20mV steps, starting at
-60mV and ending at 60mV followed by a poststep voltage of -40mV
4.1.3.2 LQT-2 Data
Measurements regarding LQT-2 data were found in [36]. The Experimental and Molec-
ular Cardiology Group and the Departments of Physiology and Clinical Genetics in the
University of Amsterdam recorded HERG current, IHERG, on wild-type and type 2 Long-
QT syndrome-associated mutant R56Q. These measurements were performed using the
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techniques mentioned in 4.1, where the values of the ion channel currents were recorded
for several transmembrane voltage values. The exact conditions in which the procedure
was carried out can be found in [36]
.
Fig. 4.5. Current-Voltage graphs for IHERG Wild Type (left) and coexpressed R56Q mutation (right)
characteristics. Different colors express different voltage clamp steps.
Fig. 4.6. Two step voltage clamp protocol for LQT-2 measurements.
By looking at both the measurement protocol and the voltage-current graphs, P1, is re-
sponsible for the activation of the current. IHERG sequentially increases and then decreases
in a response to the applied voltages. The second step, P2, stimulates the tail currents
in which the top value is a consequence of fast recovery from inactivation, whereas the
following decrease is due to deactivation.
4.2 Modelling Cardiac Electrophysiology
The possibilities for doing experimental and clinical studies involving human hearts are
very limited. Furthermore, animal hearts used for experimental studies may differ signifi-
cantly from human hearts, hence the requirement to develop computational models that
can help investigating human cardiophysiology.
Mathematical models of cardiac electrophysiology can illustrate the flow of ions into and
out of a cell or even the compartments within a cell, and can provide large amounts of
information not only about the ion channels themselves, but also about the interaction
between these channels and the electrical waves they produce.
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4.2.1 Ten Tusscher et al. Model
K. H. W. J., Ten Tusscher, D. Noble, P. J. Noble, and A. V. Panfilov formulated a model
for human ventricular cells that is based on recent experimental data and that is efficient
for large-scale spatial simulations of reentrant phenomena.
Fig. 4.7. Schematic description of the Ten Tusscher Model. From [6]
The cell membrane is modeled as a capacitor connected in parallel with variable resistances
and batteries representing the different ionic currents and pumps and the Nernst potential.
The electrophysiological behavior of a single cell can thus be described with the following
differential equation
dVm
dt
= −Iion + Istim
Cm
(4.1)
where V is voltage, t is time, Iion is the sum of all transmembrane ionic currents, Istim is
the externally applied stimulus and Cm is cell capacitance per unit surface area [37].
The set of transmembrane currents is given by
Iion = INa+ IK1 + Ito+ IKr + IKs+ ICaL+ INaCa+ INaK + IpCa+ IpK + IbCa+ IbK (4.2)
where INaCa is Na+/Ca2+ exchanger current, INaK is Na+/K+ pump current, IpCa and
IpK are plateau Ca2+ and K+ currents, and IbCa and IbK are background Ca2+ and K+
currents [37].
4.2. Modelling Cardiac Electrophysiology 25
For this work, however, we will focus on the slow and rapid delayed potassium currents
and the sodium current, being them the ones affected by the mutations in the first three
LongQT syndromes. These currents were described by Ten Tusscher et al. via the follow-
ing expressions.
Slow Delayed Rectifier Current
IKs = GKsx
2
s(V − EKs) (4.3)
xs,∞ =
1
1 + e(−5−V )/14
(4.4)
αxs =
1400√
1 + e(5−V )/6
(4.5)
βxs =
1
1 + e(V−35)/15
(4.6)
τs,∞ = αxsβxs + 80 (4.7)
xs is an activation gate with αxs and βxs its correspondent transition rates. EKs repre-
sents a reversal potential determined by a large permeability to potassium and a small
permeability to sodium and xs,∞ and τs,∞ stand for steady state activation curve and
activation steady state time constant respectively. For further information see [37] and
[38].
Rapid Delayed Rectifier Current
IKr = GKs
√
Ko
5.4
xr1xr2(V − EK) (4.8)
xr1,∞ =
1
1 + e(−26−V )/7
(4.9)
αxr1 =
450
1 + e(−45−V )/10
(4.10)
βxr1 =
6
1 + e(V+30)/11.5
(4.11)
xr2,∞ =
1
1 + e(V+88)/24
(4.12)
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αxr2 =
3
1 + e(−60−V )/20
(4.13)
βxr2 =
1.12
1 + e(V−60)/20
(4.14)
xr1 and xr2 are activation and inactivation gates respectively, with αxr1, βxr1, αxr2 and
βxr2 their correspondent transition rates. xr1,∞ and xr2,∞ stand for steady state activation
and inactivation curves.
An exhaustive description of the currents and constants can be found in [38].
4.2.2 Adjustment of Simulation Data to Measurements
The Script Optimizer of the Institute Of Biomedical Engineering is a tool for fitting func-
tions or cell models to a set of measurement points by modifying variable parameters of
the function/model. In every iteration step the ScriptOptimizer compares the difference of
the measurement points and the simulated curves and tries to adjust the variable param-
eters. These iterations are performed till the sum of the fitness values reaches a minimum.
In the present case, the objective was to construct models for myocytes affected by LQT-
1 and LQT-2 related mutations respectively, by integrating them in the Ten Tusscher
cell model. Thus, some parameters and constants in the Ten Tusscher equations for both
IKs and IKr were chosen and their values were optimized using the Script Optimizer, in
order to adjust kinetics of ionic currents to our sets of measurements. Simulations were
carried out for wild type cases and both LQT-1 and LQT-2 mutations and the optimized
parameters can be seen in tables 4.1 and 4.2.
4.2.2.1 Integration of LongQT-1 in the Model
The data presented in section 4.1.3.1 was used to construct the LQT-1 related model.
With the purpose of integrating the channel kinetics, a two-step optimization was re-
quired. It is important to keep in mind that parameters regarding temperature and ionic
distribution had to be adjusted in the original Ten Tusscher model (i.e the initial values of
the K, Na and Ca concentrations), so that the simulation conditions resembled the actual
conditions present at time of the measurement experiments.
The first step of the process covered the optimization of the slow-delayed conductance,
gKs, and the temperature correcting factor KQ10 Xs, to fit the Wild Type data. This way, a
better approximation to the control data would be achieved and the base would be settled
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to get a better approach to the data regarding the mutation, which would be the second
step of the process. The idea, a priori, was to set the new values for these two parameters
and then fit the data with the coexpression of the wild type and the mutation by just
changing parameters linked to the steady-state curve of the activation gate, the transition
rates and the time constant. However, a posteriori and after several trials, results showed
that it was necessary to include gKs in the second step and optimize it again. These first
results also revealed that not all the values present in the Ten Tusscher equations needed
to be changed.
Table 4.1. Brief description of the parameters regarding IKs to be optimized by Script Optimizer
Parameter Description Original
value
g Ks IKs conductance 0.392
K Q10 Xs Temperature correcting factor for the
activation gate xs
1
m Xs 1 Constant in the equation for the steady state
activation curve xs,∞
-5
m Xs 2 Constant in the equation for the steady state
activation curve xs,∞
14
a Xs 1 Constant in the equation for αxs 5
a Xs 2 Constant in the equation for αxs 6
b Xs 1 Constant in the equation for βxs -35
b Xs 1 Constant in the equation for βxs 15
tau Xs Constant in the equation for τs,∞ 80
4.2.2.2 Integration of LongQT-2 in the Model
For the construction of the LQT-2 related model, data presented in section 4.1.3.2 was
used. Just like in the previous case, a two-step optimization was required and parame-
ters regarding temperature and ionic distribution had to be adjusted in the original Ten
Tusscher model. However, unlike for LQT-1, the first step of the process not only covered
the optimization of the rapid-delayed conductance, gKr, and the temperature correcting
factor KQ10 Xr,1, (KQ10 Xr,1 remained with the original value) but also the constants in
the steady state activation and inactivation curves needed to be included to perform the
adjustment to the wild type data. All these parameters were included again for the ad-
justment to the coexpressed data together with constants in the transition rates. Once
again, several trials revealed that not all the values needed to be changed.
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Table 4.2. Brief description of the parameters regarding IKr to be optimized by Script Optimizer
Parameter Description Original
value
g Kr IKr conductance 0.153
K Q10 Xr 1 Temperature correcting factor for the
activation gate xr1
1
K Q10 Xr 2 Temperature correcting factor for the
inactivation gate xr2
1
m Xs 1 1 Constant in the equation for the steady state
activation curve xr1,∞
-26
m Xs 1 2 Constant in the equation for the steady state
activation curve xr1,∞
7
m Xs 2 1 Constant in the equation for the steady state
inactivation curve xr2,∞
-88
m Xs 2 1 Constant in the equation for the steady state
inactivation curve xr2,∞
24
a Xs 1 1 Constant in the equation for αxr1 -45
a Xs 1 2 Constant in the equation for αxr1 10
a Xs 2 1 Constant in the equation for αxr2 -60
a Xs 2 2 Constant in the equation for αxr2 20
b Xs 1 1 Constant in the equation for βxr1 -30
b Xs 1 2 Constant in the equation for βxr1 11.5
b Xs 2 1 Constant in the equation for βxr2 60
b Xs 2 2 Constant in the equation for βxr2 20
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4.2.3 Clancy and Rudy: Integration of LongQT-3
Unlike for LQT-1 and LQT-2, LQT-3 was integrated in the Ten Tusscher model by using
a Markovian chain, based in the Clancy and Rudy method. Clancy and Rudy developed a
model describing the physiological and mutant INa channel with a Markovian chain model.
Fig. 4.8. Markovian models for WT (A) and 1795insD (B) cardiac Na channels. Taken from [39]
.
This chain model describes the behavior of the channel and incorporates new features
to previously formulated methods. Among those new features new intermediate inactiva-
tion states can be found, to more accurately simulate channel inactivation and recovery.
IM1 keeps the majority of channels from reopening during depolarization. Two closed-
inactivation states IC2 and IC3 are introduced to represent channel availability.
Regarding the model for the mutant channel, it is composed of two modes, the background
and the burst. It can be seen that the background mode resembles the wild type, but in
this case recovery rates from inactivation are reduced and transitions into UIM1 and UIM2
are faster. The burst mode describes the behavior of the channels that fail to inactivate.
Due to these channels, late INa is generated during the Plateau phase [39].
4.2.4 Tissue Modeling
Cell modeling has been previously described but, in order to resemble the behaviour of
a group of cells, simulating the ionic flow outside the cell is of great importance. Tissue
models can reconstruct the current flowing through the intra- and extracellular space, and
through the gap junctions. The most important models for the propagation of electrical
impulses in the cardiac tissue are the bidomain and monodomain models.
4.2.4.1 Bidomain Model
The bidomain model describes the intra- and extracellular space as two domains sepa-
rated by the cell membrane. Conductivity tensors for each domain are integrated, which
considers the anisotropic electrical properties of the tissue, which are different in each of
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the spaces (fiber orientation dependent outside the cell and gap junction density depen-
dent inside of it). Thus, anisotropy can vary from cell to cell. The distribution of electric
potentials can be described for each domain with the Poisson’s equation for stationary
electrical field as follows:
∇(σe∇Φe) = −βIm − Ise (4.15)
∇(σi∇Φi) = βIm − Isi (4.16)
where Φi and Φe are the intra- and extracellular potentials, respectively, σi and σe the
corresponding volume-averaged conductivity tensors, Im the transmembrane current den-
sity, β the surface to volume ratio of the cell, and Isi and Ise an externally applied current.
Fig. 4.9. The two domains of the bidomain model. The intracellular space is separated from the extra-
cellular space by a membrane. Adapted from [40]
.
Conductivity tensors represent the conductivities in longitudinal σ(e,i)l and transversal
σ(e,i)t directions of the fiber. The orientation of the main axis of the fiber in the global
coordinate system is expressed by the rotation matrix R
σ(e,i)global = R
σ(e,i)l 0 00 σ(e,i)t 0
0 0 σ(e,i)t
RT (4.17)
The rotation matrix is conducted of two components Rxy and Rxz, whereas R equals
RxyRxz:
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Rxy =
 cosψ sinψ 0− sinψ cosψ 0
0 0 1
 (4.18)
Rxz =
 cos θ 0 sin θ0 1 0
− sin θ 0 cos θ
 (4.19)
φ describes the angle of the fibre orientation in the (x,y)-plane and θ describes the angle
of the fibre orientation in the (x,z)-plane. The transmembrane voltage can be calculated
as follows:
Vm = Φi − Φe (4.20)
Summing the previous Poisson’s equations we reach the following
∇(σi∇Φi) = −∇(σe∇Φe) (4.21)
∇(σi∇(Vm + Φe)) = −∇(σe∇Φe) (4.22)
∇(σi∇Vm) +∇(σi∇Φe) = −∇(σe∇Φe) (4.23)
∇((σi + σe)∇Φe) = −∇(σi∇Vm) (4.24)
This first bidomain equation describes the effect of the transmembrane voltage on the
extracellular potential. For the second bidomain equation, Poisson equation 4.15 can be
rewritten using 4.20 leading to:
∇(σi∇Φi) = ∇(σi∇(Vm + Φe)) = ∇(σi∇Vm) +∇(σi∇Φe) = −βIm − Isi (4.25)
According to Hodgkin and Huxley [41], Im can be described as
Im = βm(Cm
dVm
dt
+ Imem) (4.26)
and combining that with the previous findings, we reach to the second bidomain equation:
∇(σi∇Vm) +∇(σi∇Φe) = β(CmdVm
dt
+ Imem)− Isi (4.27)
4.2.4.2 Monodomain Model
The monodomain model is just a simplified version of the just explained bidomain model.
In this case, the anisotropy ratio will be considered equal in both sides of the cell, and thus
the conductivities will only differ in a constant scalar (σe = kσi). Therefore, the resulting
equation will be the following:
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∇(σi∇Vm) = −((σi+ σi
k
)∇Φe) = −(1+ 1
k
)∇(σi∇Φe) = (k+1)β(CmdVm
dt
+Imem) (4.28)
4.2.5 Anatomical Modeling
Magnetic resonance images were used to build the anatomical models of the ventricles
and the torso. With the purpose of conducting the forward calculations, the voxels in the
torso model were converted to tetrahedrons and the node-density of the resulting mesh
was higher in the heart than anywhere else. More information can be found in [42].
4.2.6 Forward Calculation of the ECG
Different transmembrane voltage distributions were obtained from each of the various het-
erogeneous electrophysiological configurations explained in section 4.3. After interpolating
these distributions onto the anatomical model described above, extracellular potentials
were determined by applying the bidomain equations. Details on this procedure can be
found in [43].
At the same positions that were used for the multichannel ECG recording (see section
4.3.2) we extracted body surface potentials. The position of the electrodes and a visual-
ization of the thoracic model can be found in [42].
4.3 Adjustment of the T-wave
It is commonly accepted that the associated dispersion of repolarization (DOR) is mainly
responsible for the shape of the T-Wave, although its concordance and exact morphology
remain not completely understood. DOR is due to differences in action potential duration
in myocytes from different regions of the heart and in human cardiac myocytes the slowly
delayed rectifier current IKs is believed to be mainly responsible for these regional dif-
ferences [44]. In this work, the density of IKs was varied and heterogeneously distributed
in different ways throughout the ventricles, creating different types of DOR. Activation
and repolarization of the different heterogeneous IKs distribution models were calculated
using the Ten Tusscher model, and body surface ECGs were simulated and compared to
multichannel ECG data in an effort to evaluate the realism of the calculated ECGs.
4.3.1 Electrophysiological Heterogeneities
In order to construct the different configurations of heterogeneous IKs densities, previous
data regarding the topic was gathered from [45] and, based on it, 22 different setups were
created. The heterogeneously distributed parameter (gKs) was stored in a dataset with the
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same resolution as the anatomical model. Before ventricular activation was initiated, the
simulation framework [46] loaded this dataset and replaced gKs in the electrophysiological
model with these values.
4.3.1.1 Transmural Heterogeneities
Concerning the distribution of transmural heterogeneities, many different studies reported
a shorter Endo compared to Epi APD [45]. This was considered by reducing the Endo
gKs to 92% of its Epi value according to [47]. All other parameters were taken from the
original Ten Tusscher et al. publication. Endo, M and Epi cells were arranged in layers of
different thicknesses, resulting in the following setup.
• TM40 30 30: this setup contained 40% Endo, 30% M and 30% Epi cells. The val-
ues of the conductivity for the different cell types were gKs,Endo=0.36064 nS/pF,
gKs,M=0.098 nS/pF and gKs,Epi=0.392 nS/pF
4.3.1.2 Apico-Basal Heterogeneities
When it comes to apico-basal APD dispersion, different studies show both larger and
smaller APDs in the apex compared to the base. Moreover, the IKs density was found
to be a bit less than twice as large in apical than in basal myocytes [48]. However, [45]
showed that the results were better in the case of gKs being larger at the apex and that
a scaling factor of 1.5 wasn’t enough. Therefore, due to the fact that the left ventricle
mostly consists of Endo cells, [49] this cell type with its specific gKs value of 0.36064
nS/pF was taken as a basis and different scaling factors were applied to accomplish the
gradient. We first chose to model a 2 times larger IKs density at the apex and then a
second model where IKs was 2.25 times larger at the apex. The values in between were
linearly interpolated.
• A2B1: Endo gKs was multiplied by scaling factors from 1 in the base to 2 in the apex.
(gKs,base=0.36064 nS/pF , gKs,apex=0.72028 nS/pF)
• A2.25B1: Endo gKs was multiplied by scaling factors from 1 in the base to 2.25 in
the apex. (gKs,base=0.36064 nS/pF , gKs,apex=0.81144 nS/pF)
4.3.1.3 Diagonal Heterogeneities
In the previous apico-basal setups the gradient followed a vertical vector starting at the
apex and finishing at the base. In order to study if the heterogeneities could be distributed
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Fig. 4.10. Apico-Basal setups and the corresponding scaling factors
along a different direction we created two configurations in which the gradient followed a
diagonal. In the first one, the gradient was set in the direction of the normal vector of a
plane that conformed a 45 degree angle with the right ventricle apex. For the second, the
plane conformed a 45 degree angle with the left ventricle apex and the gradient followed
the direction of the normal vector. The scaling factor was 2 for the starting apex-corner
and 1 for the ending base-corner. As in the apico-basal case, Endo cells were chosen for
these configurations.
• A2B1 45deg RV: Endo gKs was multiplied by scaling factors from 1 in the left
ventricular base to 2 in the right ventricular apex. (gKs,Leftbase=0.36064 nS/pF ,
gKs,Rightapex=0.72028 nS/pF)
• A2B1 45deg LV: Endo gKs was multiplied by scaling factors from 1 in the left
ventricular base to 2 in the right ventricular apex. (gKs,Rightbase=0.36064 nS/pF ,
gKs,Leftapex=0.72028 nS/pF)
2
1
Scaling factor
(dimensionless)
2
1
Scaling factor
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Fig. 4.11. Diagonal setups and the corresponding scaling factors. Note how the gradient follows a
diagonal.
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4.3.1.4 Combination of Apico-Basal and Transmural Heterogeneities
In order to include both apico-basal and transmural gradients at the same time, we mul-
tiplied different transmural setups by the scaling factors in the previously mentioned
apico-basal configurations. The first transmural setups used for this combinations were
chosen based on results in [45] and, from then on, the rest were randomly created by
analyzing previous trials. This led to 10 setups:
• TM40 30 A2B1: a transmural setup containing 40% of Endo, 30% of M and 30% of
Epi cells was multiplied by the scaling factors in A2B1
• TM40 A2.25B1: a transmural setup containing 40% of Endo, 30% of M and 30% of
Epi cells was multiplied by the scaling factors in A2.25B1
• TM35 40 A2B1: a transmural setup containing 35% of Endo, 40% of M and 25% of
Epi cells was multiplied by the scaling factors in A2B1
• TM35 40 A2.25B1: a transmural setup containing 35% of Endo, 40% of M and 25%
of Epi cells was multiplied by the scaling factors in A2.25B1
• TM35 30 A2B1: a transmural setup containing 35% of Endo, 30% of M and 35% of
Epi cells was multiplied by the scaling factors in A2B1
• TM35 20 A2.25B1: a transmural setup containing 35% of Endo, 20% of M and 45%
of Epi cells was multiplied by the scaling factors in A2.25B1
• TM30 30 A2B1: a transmural setup containing 30% of Endo, 30% of M and 40% of
Epi cells was multiplied by the scaling factors in A2B1
• TM25 40 A2B1: a transmural setup containing 25% of Endo, 40% of M and 35% of
Epi cells was multiplied by the scaling factors in A2B1
• TM20 15 A2.25B1: a transmural setup containing 20% of Endo, 15% of M and 65%
of Epi cells was multiplied by the scaling factors in A2.25B1
• TM10 15 A2.25B1: a transmural setup containing 10% of Endo, 15% of M and 85%
of Epi cells was multiplied by the scaling factors in A2.25B1
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TM25_40_A2B1 TM30_10_A2B1 TM30_30_A2B1
TM_35_30_A2B1 TM_35_35_A2B1 TM35_40_A2B1
TM_40_30_A2B1
0.098 nS/pF
0.784 nS/pF
Fig. 4.12. Setups including apico-basal and transmural gradients at the same time
Figure 4.12 shows how by changing the percentages of the different cell types, not only
the amount of M cells is changed but also their position. Depending on the setup, M cells
appear closer to the endocard or to the epicard and the thickness of the corresponding
layer increases or decreases.
4.3.1.5 Reduced gKr
As explained in the theoretical introduction, both IKs and IKr are mainly responsible for
the repolarization, specially for the late repolarization. Thus, another option that we con-
sidered was to decrease the original value of gKr in the Ten Tusscher model. Consequently,
we first chose setups with an apico-basal gradient and reduced the gKr to a 50, 20 and
10 percent of the original value. In addition, configurations with combined (apico-basal
and transmural) heterogeneities were elected and gKr was decreased to a 10 percent of its
original value.
As a result, 7 configurations were obtained:
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• A2B1 50percent: the original value of gKr in the A2B1 setup was divided by a factor
of 2.
• A2B1 20percent: the original value of gKr in the A2B1 setup was divided by a factor
of 5.
• A2B1 10percent: the original value of gKr in the A2B1 setup was divided by a factor
of 10.
• TM30 10 A2B1 10percent: the original value of gKr in the combined setup TM30 10 A2B1
was divided by a factor of 10.
• TM35 35 A2B10percent: the original value of gKr in the combined setup TM35 35 A2B1
was divided by a factor of 10.
• TM40 30 A2.25B10percent: the original value of gKr in the combined setup
TM40 30 A2.25B1 was divided by a factor of 10.
• TM40 30 A2B10percent: the original value of gKr in the combined setup TM40 30 A2B1
was divided by a factor of 10.
4.3.2 Multichannel ECG Recording
Simulated T-waves needed to be compared to a set of measurements. For this measure-
ments to be performed, a 64-lead system (ActiveTwo, BioSemi, Amsterdam, Netherlands)
was used to record multichannel ECG data at 70 beats per minute. The common-mode
rejection ratio was increased with the objective of denoising and the reference point was
moved to Wilson Central Terminal for the same reason.[50].
116 successive heartbeats were averaged on every channel so that comparison with the
simulation results was possible.
4.4 BSPM Simulation
After developing cell models for the Long-QT subtypes and adjusting the T-wave by
choosing a setup to model the physiological heterogeneity, Body Surface Potential Maps
(BSPM) were simulated all over the thorax for the physiological case and the three sub-
types. Nodes were chosen so that the minimum distance among them was 1.7cm leading
to 1050 nodes, thus, 1050 signals for each of the cases.

5Results
The aim of this work was to analyze the differences in BSPM for each of the first three
Long-QT syndromes and try to select electrodes in which those differences were signifi-
cant. For this purpose, cell models for the syndromes were developed first; more precisely
channel kinetics and current reductions were integrated in the Ten Tusscher model as ex-
plained in sections 4.2.2.1 and 4.2.2.2. APD was simulated for the physiological case and
the three subtypes and restitution functions such as ERP, CV and WL were compared
as well. In parallel to those tasks, the physiological heterogeneity in the heart and torso
model was adjusted so that the simulated T-wave resembled the measured BSPM. Once
the effects of Long-QT 1, 2 and 3 were modeled and the best approach for the T-wave
was chosen, BSPM were simulated for the subtypes and, finally, differences between them
were evaluated and analyzed not only regarding amplitude but also morphological descrip-
tors for the T-wave. This chapter presents the results obtained in each step of this analysis.
5.1 Parameter Optimization
In order to integrate the effects of LongQT-1 and LongQT-2 in the model, a parameter
optimization was performed with the help of the Script Optimizer in which parameters
were adjusted to fit both the wild type data and the coexpressed.
5.1.1 LongQT-1
The results for IKs are shown in figure 5.1. In spite of the fact that the tail current didn’t
really fit, the results were on the whole satisfactory. Since the current present during the
clamp step is more important for cell physiology in general, the main focus was to adjust
this current as good as possible which was mainly achieved, although the simulated cur-
rents could not reach the peak value of the measurements in some of the cases, especially
40 Chapter 5. Results
regarding the wild type data.
Fig. 5.1. Comparison of simulated current-voltage graphs and measurements for both LQT-1 wild type
(top) and coexpressed (bottom) data. Solid lines represent the set of measurements, whereas dashed lines
show the results of the simulations.
As explained in section 4.2.2, a two-step optimization was required in which gKs and
KQ10 were adapted to the wild type set of measurements and, with the obtained values,
an adjustment to the coexpresssed data was performed, in which gKs was again varied,
together with the remaining parameters. In order to construct a model for the subtypes
of the LongQT syndrome, the temperature, ionic distribution and KQ10 had to be set to
the original values. The value of gKs had to be suited by combining the original value in
the Ten Tusscher model and both values obtained in the optimization for the wild type
and the coexpressed data. This was made by using the following formula:
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gKs,LQTModel =
gKs,origgKs,Coex
gKs,WildType
(5.1)
Table 5.1. Values of the parameters regarding IKr provided by Script Optimizer and final values used
for the Ten Tussher based LQT1 cell model
Parameter Original
value
Adjustment to
Wild Type Data
Adjustment to
Coexpressed Data
Final Value for
the LQT1 Model
based on eq. 5.1
g Ks 0.392 0.01037 0.00422 0.159
K Q10 Xs 1 1.909 – 1
m Xs 1 -5 – -32.8719 -32.8719
m Xs 2 14 – – 14
a Xs 1 5 – -19.3863 -19.3863
a Xs 2 6 – 0.2885 0.2885
b Xs 1 35 – 27.7474 27.7474
b Xs 2 15 – 22.2581 22.2581
tau Xs 80 – – 80
Table 5.1 shows the output values from the Script Optimizer adjustment and the final
values used for the Ten Tusscher based LQT-1 cell model, where gKs was obtained by
using the previously mentioned formula. Some of the constants that were initially thought
to be included for fitting the coexpressed data were set to the original values after an a
posteriori analysis of the first trials showed that better approximations to measurements
were accomplished this way. Changes in the parameters are quite significant in most of
the cases, specially for the conductivity, which presents an expected reduction.
5.1.2 LongQT-2
The results for IHERG are shown in figure 5.2. The sets of measurements for LQT-2 were
more complicated to fit and, again, the main focus was to adjust the currents present
during the clamp step, hence the lack of resemblance when it comes to tail currents. Just
like for the LQT-1 data, simulations couldn’t reach the highest current values in some of
the cases and tended to stabilize faster than the measured IHERG.
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Fig. 5.2. Comparison of simulated current-voltage graphs and measurements for both wild type (top) and
LQT-2 coexpressed (bottom) data. Solid lines represent the set of measurements, whereas dashed lines
show the results of the simulations.
Unlike for LQT-1, not only gKr and the temperature correcting factors were adapted
to the wild type set of measurements, but the constants present in the equations for the
activation and inactivation steady state curves as well. The adjustment to the coexpresssed
data included those parameters again together with the remaining. Once again, setting
the temperature, ionic distribution and the temperature correcting factors back to the
original values was necessary. gKr was recalculated using equation 5.1 and the constants
present in the equations for the activation and inactivation steady state curves were suited
by combining the original value in the Ten Tusscher model and both values obtained in the
optimization for the wild type and the coexpressed data by using the following formulas:
m Xr i 1LQTModel = m Xr i 1orig −m Xr i 1WT +m Xr i 1Coex (5.2)
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m Xr i 2LQTModel =
m Xr i 2origm Xr i 1Coex
m Xr i 2WT
(5.3)
where i = 1,2
Table 5.2. Values of the parameters regarding IKr provided by Script Optimizer regarding the LQT2
model.
Parameter Original
value
Adjustment to
Wild Type Data
Adjustment to
Coexpressed Data
Final Value for
the LQT2 Model
based on
eqs. 5.2-5.3
g Kr 0.153 0.05099 0.04358 0.125
K Q10 Xr 1 1 5.0457 – 1
K Q10 Xr 2 1 – – 1
m Xr 1 1 -26 0.9362 -17.03 -43.96
m Xr 1 2 7 7.427 7.694 7.251
m Xr 2 1 -88 25.324 17.861 -95.463
m Xr 2 1 24 19.3867 20.984 25.977
a Xr 1 1 -45 – -15.7865 -15.7865
a Xr 1 2 10 – 13.8433 13.8433
a Xr 2 1 -60 – 55.3022 55.3022
a Xr 2 2 20 – – 20
b Xr 1 1 -30 – -44.0902 -44.0902
b Xr 1 2 11.5 – 10.5209 10.5209
b Xr 2 1 60 – – 60
b Xr 2 2 20 – – 20
Table 5.2 shows the output values from the Script Optimizer adjustment and the final
values used for the Ten Tusscher based LQT-2 cell model. Final values for the parameters
that were changed for both the adjustment to the wild type data and the adjustment to
the coexpressed data were obtained by using the previously mentioned set of equations.
As in the optimization for LQT-1 data, some of the constants that were initially thought
to be included for fitting the coexpressed data were set to the original values after an a
posteriori analysis of the first trials showed that better approximations to measurements
were accomplished this way. Unlike for LQT-1, the change in the value of the conductivity
is not very significant, although we observe an expected reduction. Most of the remaining
constants don’t experience as meaningful alterations as in the previous case.
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5.2 Restitution Functions
Once the effects of the three LongQT subtypes were integrated in the Ten Tusscher model,
restitution parameters were simulated together with the physiological case. Action po-
tentials for the four cases were obtained and, along with that, the wavelength (WL),
conduction velocity (CV) and the effective refractory period (ERP) were also calculated.
The wavelenght is the distance travelled within a refractory period, thus, WL defines the
shortest path length that is able to sustain reentry and it is described as the product of
the CV and the ERP. One cycle of a stimulus is made up of the actual action potential
and the period during which a steady state is maintained. This period is called diastolic
interval (DI). The sum of APD and DI is the basic cycle length (BCL).
Fig. 5.3. APD for the Long-QT subtypes and the physiological case.
Fig. 5.4. Restitution Functions CV represented against BCL
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Fig. 5.5. Restitution Functions ERP represented against BCL
Fig. 5.6. Restitution Functions WL represented against BCL
As expected, all the action potentials for Long-QT subtypes present a prolongation (fig
5.3). This prolongation is more significant for the LQT1 case and least significant when
it comes to LQT2. The CV, ERP and WL are shown in figure 5.6. The curves for the
physiological case and the first two subtypes are similar, only LQT3 follows a different
pattern.
5.3 Adjustment of the T-wave
To allow a visual evaluation of the T-wave for each of the heterogeneous configurations,
cropped T-waves corresponding to the Einthoven II lead are shown compared to measure-
ments in figure 5.7. All the signals were normalized to their respective R-peak amplitude
in the Einthoven II lead to eliminate influences of the measurement system, which is re-
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sponsible for the absolute signal amplitude. Signals are grouped in categories: transmural,
apico-basal, diagonal, combined and gKr-reduced.
Fig. 5.7. Cropped T-waves of the Einthoven II leads for all the heterogeneous setups. Waves for transmural
setups can be seen at the top left corner, for apico basals at the top right, diagonals at the mid left, combined
at the mid right and gKr-reduced at the bottom
A more quantitative analysis is presented in table 5.3 where medians of the correlation
coefficients and RMSEs over all electrodes between the measured and the simulated ECGs
from the different heterogeneous configurations are shown in order to compare them with
the measured T-Wave. These parameters were calculated in a window with only a cropped
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T-Wave and parts of the ST segment since the QT times in each of the simulations were
different. The window for the measured wave was chosen by finding the position of the
maximum in an arbitrary lead with a positive T-Wave. Once that point was obtained, the
starting point for the window was set to 160ms before, and the ending point to 100ms
after which resulted on a 261ms-long window. For the simulated waves, on the contrary, it
was necessary to find the best window position. With that purpose, the initial window was
determined in the same way as for the measured wave and used as an initial guess. After
that, the absolute value of the correlation coefficient between the simulated wave and the
measured was calculated for each of the electrodes so that the median of those absolute
coefficients could be found. Good alignment between measurements and simulations in
all electrodes was represented by large values of those medians. In order to find the best
plausible alignment, the window was symmetrically shifted in a 40ms interval around the
T-Wave maximum. The optimum window position was chosen according to the largest
value among the median of the absolute correlation coefficients for each window position.
Table 5.3. Medians of the correlation coefficients and RMSEs over all electrodes between the measured
and the simulated ECGs from the different heterogeneous configurations.
Setup Median Correlation
Coefficient
Median RMSE
TM30 10 A2B1 10percent 0.93525 0.081873
A2B1 10percent 0.92226 0.073216
A2B1 20percent 0.92226 0.073216
A2B1 50percent 0.9129 0.075112
TM20 15 A2.25B1 0.90819 0.111
TM10 15 A2.25B1 0.90552 0.1176
A2B1 0.89901 0.076336
TM30 A2B1 0.89658 0.082341
TM35 30 A2B1 0.896 0.079551
TM35 20 A2.25B1 0.89581 0.087372
TM40 30 A2.25B10percent 0.87987 0.078626
TM25 40 A2B1 0.87958 0.087656
A2.25B1 0.87822 0.0813
TM35 35 A2B1 10percent 0.86901 0.072691
A2B1 45deg LV 0.86573 0.085492
A2B1 45deg RV 0.83026 0.072916
TM40 30 A2.25B1 0.82906 0.078969
TM30 30 40 0.82506 0.071342
TM40 A2B1 0.82236 0.070918
TM40 30 A2B1 10percent 0.81422 0.069322
TM35 40 A2B1 0.80652 0.073703
TM35 40 A2.25B1 0.79998 0.08124
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Table 5.3 shows the median of the correlation coefficients (without absolutes in this case)
and the median of the root mean square error (RMSE) in that window between each setup
and the measurement. Setups are arranged by CC from bigger to smaller. The correlation
coefficient just considers alignment, hence the need to calculate the RMSE to take ampli-
tude into account. Similarly to the correlation coefficients, it was calculated over all the
electrodes and the median was extracted from those values.
The best resemblance between the simulated and the measured signals is represented by a
large CC and a small RMSE. Results concerning CC were on the whole very satisfactory,
reaching a correlation of the 92% in the best case and 79% in the worst. As observed,
setups with gKr reduction often show a higher correlation coefficient, presenting the four
setups with highest values this kind of heterogeneity. However, those setups were not
valid for our work, since the reduction in the conductivity causes itself a prolongation
of the QT time and that would interfere with the research. Nevertheless, they provided
a better understanding of the morphology of the T-wave. The setups TM20 15 A2.25B1
and TM10 15 A2.25B1 also presented fairly high CCs but the RMSE was big enough to
discard them as well. As we wanted to include combined heterogeneities, A2B1 was also
eliminated and between TM30 A2B1 and TM35 30 A2B1 having the last one a smaller
RMSE for a similar CC, finally TM35 30 A2B1 was the chosen.
5.4 BSPM Analysis
After developing cell models for the Long-QT subtypes and adjusting the T-wave by
choosing a setup to model the physiological heterogeneity, Body Surface Potential Maps
(BSPM) were simulated all over the thorax for the physiological case and the three sub-
types. Nodes were chosen so that the minimum distance among them was 1.7cm leading
to 1050 nodes, thus, 1050 signals for each of the cases.
Einthoven leads for all the cases are compared in figure 5.8-5.10 to get a visual concept
of the simulated ECGs. All the subtypes show a prolongation in the QT time, although
less significant than expected, specially for LQT-2 and LQT-3. For comparative reasons,
the average QT time was calculated over the 1050 nodes. With that purpose it was neces-
sary to determine the Tend time, which corresponds to the end of the T-wave. There are
different methods to determine this point and we used a variant of the so called tangent
method. A tangent line to the steepest point of the descending limb of the T wave was
constructed and the end of the T wave was defined as the point where this line inter-
sected zero. This was done over all the signals and it is important to note that not all of
them had positive T-waves, but also negative and biphasic. In any case, the method was
the same, only negative T-waves and biphasic T-waves with a notch after an initial peak
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were turned upside down before the method was applied. The mean of the QT time was
calculated over all the signal set.
Fig. 5.8. Einthoven lead I for the simulated BSPM including the normal case and the three Long-QT
subtypes.
Fig. 5.9. Einthoven lead II for the simulated BSPM including the normal case and the three Long-QT
subtypes.
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Fig. 5.10. Einthoven lead III for the simulated BSPM including the normal case and the three Long-QT
subtypes.
Table 5.4 shows the average QT times for all the cases. As expected, this time is longer
for the subtypes, being the longest for LQT-1 and the shortest for LQT-2. However, they
still don’t fit reality in an accurate way, since prolonged QT times appear to be shorter
than realistic QT times for the Long-QT syndrome [51].
Table 5.4. Average QT times for the normal case and the three subtypes
Normal LongQT-1 LongQT-2 LongQT-3
Avg QT
time (ms)
380.1560 404.9741 386.1057 393.5384
5.4.1 Differences Between Subtypes
The first approach to determine if there were differences between each subtype was the
subtraction of signals. Being just the T-wave the point of our interest, the QRS complex
was eliminated from the signals and our analysis was focused on a cropped T-wave. Sub-
types were arranged in pairs (LQT-1 to LQT-2, LQT-1 to LQT-3 and LQT-2 to LQT-3)
and the subtype with the longest QT time was shifted the averaged shifted time, which
was calculated over the 1050 signals as well. Once we got the T-waves lying on top of each
other, a regular subtraction was performed. As our interest was not quantitative regarding
the values of the differences, we focused on identifying the nodes in which the differences
were maximal and enumerated ten of them (table 5.5 shows them for all the cases and
arranged by absolute differences in a descendant way).
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Table 5.5. Numbers identifying the nodes in which the differences between subtypes are more significant
LQT1 to LQT2 LQT1 to LQT3 LQT2 to LQT3
176967 1232 176967
10766 278176 23457
75970 59187 75970
83 351375 83
11049 23457 64700
323596 42096 20668
38540 34981 1232
73008 64700 18393
14255 9390 323596
267405 7406 11049
Note how some nodes appear in both LQT-1 to LQT-2 and LQT-2 to LQT-3 in the same
positions, i.e 176967 shares first position in both cases, 75970 is third and 83 fourth. That
gives us an idea about the regions where the differences are significant being similar for
both cases. A more visual analysis of the differences can be seen in appendix B, where
evolutions of the ECGs can be found. First, voltages during the T-wave are displayed for
each of the subtypes (LQT-1, LQT-2 and LQT-3) and, after, the voltages resulting from
the subtraction (explained above) are displayed for each of the compared cases.
5.4.1.1 Descriptors for the Morphology of the T-wave
The subtraction of T-waves gives an idea about differences in amplitude, but differences
in the morphology of the wave are also interesting to compare. Due to difficulties to
choose correct descriptors for biphasic waves, only monophasic waves were analyzed with
this procedure. Negative waves were twisted to make the analysis easier. With that in
mind, we chose 3 descriptors: kurtosis, skewness and flatness, being the flatness the differ-
ence between the Tend time and the time correspondent to the maximum peak of the wave.
To perform a correct comparison of the mentioned descriptors, T-waves needed to be
cropped in such a way that the window was equally sized for all of them and the peak
of the wave was located exactly in the middle. The window size was determined by the
wave with maximum Tpeak-Tend distance. Once that wave was found, the end point of the
window was chosen to be 102% of its Tend and the window length was set to double the
distance from Tpeak to the end point. All signals were cropped according to that size, the
kurtosis, skewness and flatness were calculated and differences between these parameter
values were computed for all the comparison cases. As for the differences, our interest
was not quantitative regarding the values of the descriptors so we focused on identifying
the nodes in which the differences between parameters were maximal and enumerated
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four nodes for each descriptor. Tables 5.6, 5.7 and 5.8 show the numbers of those nodes
arranged by values of the differences in a descendant way.
Table 5.6. Kurtosis. Numbers of the nodes in which the differences between subtypes are more significant
LQT1 to LQT2 LQT1 to LQT3 LQT2 to LQT3
9702 31494 31494
15623 9702 282462
31494 282462 25529
11987 11987 145224
Table 5.7. Skewness. Numbers of the nodes in which the differences between subtypes are more significant
LQT1 to LQT2 LQT1 to LQT3 LQT2 to LQT3
15623 31494 31494
27921 15623 282462
31494 27921 19026
176967 282462 265807
Table 5.8. Flatness. Numbers of the nodes in which the differences between subtypes are more significant
LQT1 to LQT2 LQT1 to LQT3 LQT2 to LQT3
9702 267488 267488
83 83 265807
27921 9702 19026
176967 176967 305917
6Summary
Long-QT syndrome affects up to 1 out of 2500 people and it’s a common cause of sudden
cardiac death among children and young population. Diagnosis and subtyping developed
methods so far are not as accurate as desired, though. Being genetic testing the main
subtyping procedure and the fact that many Long-QT-causing mutations still remain
undiscovered are possible reasons to explain the lack of accuracy. Hence the need to think
of alternative ways to face this disorder.
Researchers in the Institute of Biomedical Engineering at the Karlsruhe Institute of Tech-
nology [52] brought up the possibility to distinguish between Long-QT subtypes by in-
vestigating extracellular potential distributions in BSPM. In this work, this possibility
was examined and thoroughly studied by developing Long-QT related cell models and
simulating BSPM.
For that reason, channel kinetics related to pathological mutations were adjusted and in-
tegrated into the Ten Tusscher model for ventricular myocytes. LQT-1 and LQT-2 were
adjusted by extracting current-voltage graphs from literature, and a parameter optimiza-
tion regarding steady state time constants and activation and inactivation curves was
performed. Simulations resulted in smaller values of the conductivity and changes in gat-
ing constants, slightly more significant in the LQT-1 case. The LQT-2 data turned out to
be a bit more difficult to fit. The LQT-3 was integrated by using the Markov chain that
Clancy and Rudy presented in [39]. Simulated APD showed, indeed, that the Long-QT
cell models provoked a prolongation of the action potential duration. However the LQT-2
case didn’t fulfill our expectations.
In parallel to that task, it was necessary to adjust the T-wave to measured BSPM by
distributing IKs heterogeneously throughout the ventricles. Taking [45] as a basis, 22 dif-
ferent heterogeneous gKs distributions were created, leading to different types of DOR:
Transmural, Apico-Basal, Diagonal and gKr reduced. On the whole, high correlation was
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achieved when compared to measurements, being 92 % the highest correlation coefficient
and 72 % the lowest. The RMSE values were acceptable, although still a bit higher than
desired. The gKr reduced group showed higher correlation coefficients when compared to
the actual T-wave, which enables a new approach to the understanding of the T-wave,
since it shows that toggling not only gKs but also gKr has effects on it. However, as
the gKr reduction has an effect on the QT time, we discarded those configurations when
choosing the best one for our study. Although none of the tested configurations was able
to reproduce the measured wave completely, a combined transmural and apico-basal setup
with 35% of Endo, 30% of M and 35% of Epi cells was chosen due to its high correlation
coefficient and acceptable RMSE.
The last step of this study involved the simulation of BSPM including the subtypes and
the selected heterogeneous gKs distribution. 1050 nodes on the body surface were picked
and ECGs were obtained from simulations. Being our interest to make a distinction be-
tween subtypes, we arranged the syndromes in pairs (LQT-1 to LQT-2, LQT-1 to LQT-3
and LQT-2 to LQT-3) and performed two different analysis. Regular signal subtraction
showed that the order in the magnitude of the differences was around 1% of the order of
magnitude of the voltage values themselves (see appendix B). Nevertheless, it was possi-
ble to visualize different patterns in each of the compared cases (see appendix C) and so
specific electrodes in the a small area could be pointed as potential discrimination sources.
When it comes to morphological evaluation, three descriptors were elected to perform our
study: kurtosis, skewness and flatness. Appendix B shows that T-waves extracted from
the same nodes present more similarities than differences. Anyhow, electrodes could also
be elected after computing the differences in the mentioned descriptors.
The results obtained in this study show that further research is needed in this area, because
even though differences were found between BSPM distributions for each subtype, the
magnitude of these non similarities is smaller than desired and might not be enough to
state that there is a possibility to distinguish subtypes via BSPM. In any case, a better
understanding of the gKs distribution concerning the T-wave was provided and new paths
were opened to future investigations.
7Discussion and Outlook
The results in this work are not significant enough to make definitive statements regarding
the possibility to distinguish between Long-QT subtypes by BSPM in certain electrodes.
However, it provided a start point for future research and opened a path regarding the
understanding of the T-wave.
The selected data regarding LQT-2 turned out not to be the best choice, leading to a
complicated adjustment and not a very good example of APD prolongation. It would be
desirable, thus, to find another source for IHERG measurements and develop a cell model
in which the altered constants resembled the LongQT syndrome type 2 in a better way.
Better adjustments could have probably been achieved by including more parameters in
the optimization process. Nonetheless, the aim of this work was to try to emulate reality
in the best possible way, hence not many parameters being toggled.
Regarding the T-wave adjustment, reproducing the measured signal was a challenging
task. Better approximations still remain to be achieved, although some of the tested con-
figurations led to satisfactory results. It is difficult to predict how different types of DOR
affect the shape of the T-wave, specially regarding transmural setups, where the effects of
moving M-cells closer to the epicardium or the endocardium, or having a smaller amount
of M-cells are still not very clear. When it comes to apico-basal setups, though, an in-
crease in the gradient appears to cause an enlargement of the T-wave amplitude. All the
setups fail at resembling the width of the measurements, but a reduction in gKr seemed to
increase the width without provoking a prominent alteration in the amplitude. Therefore,
it would be interesting to continue research in this direction.
The simulated BSPM for the Long-QT subtypes were concordant when compared to the
simulated physiological case, presenting all of them the expected enlargement on the QT
time. However, there is still work to do, since neither of the cases matches reality (QT
times appear shorter that they are in measured ECGs). Definitions of normal QT varies
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around being equal to or less than 400 [53], 410 [54], 420 [55] or 440 miliseconds [56]. An
abnormal QT in males is a QT time above 450 ms, and in females, above 470 ms [51].
Consequently, taking a look at table 5.4 it can be seen how our QT times are shorter than
realistic.
Furthermore, depending on the observed body surface point, the T-waves could be classi-
fied in monophasic positive, monophasic negative or biphasic. An interesting characteristic
that emerged from this work is the concordance between T-waves resulting from different
types in the same nodes. For instance, waves extracted from the same node would belong
to the same class in most of the cases and present very little differences. In spite the fact
that they were very small, it was still possible to extract specific electrodes presenting
more detectable dissimilarities and to observe patterns in the distribution of the T-waves
and the T-wave differences. However, better data gathering and further research would
clarify the black spots in this work.
In conclusion, the hypothesis of detecting Long-QT subtypes via BSPM still remains
plausible, even though further investigation is needed.
AT-Wave Comparison
With the purpose of allowing a clearer view of the T-waves for the different heterogeneous
distributions explained in section 4.3, the following figures are an expanded version of
figure 5.7. It is important to keep in mind that this allows a mere visual evaluation and
that what appears here is just the Einthoven II lead. Therefore, if some of the results here
seem to mismatch the quantitative analysis in table 5.3 it is important to remember that
the CC and RMSE have been calculater over all the leads.
Fig. A.1. Cropped T-waves of the Einthoven II leads for setups with transmural heterogeneities.
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Fig. A.2. Cropped T-waves of the Einthoven II leads for setups with apico-basal heterogeneities.
Fig. A.3. Cropped T-waves of the Einthoven II leads for setups with diagonal heterogeneities.
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Fig. A.4. Cropped T-waves of the Einthoven II leads for setups that combine both apico-basal and
transmural heterogeneities.
Fig. A.5. Cropped T-waves of the Einthoven II leads for setups with reduced gKr.

BT-Wave Analysis 1
In order to have a visual perception of the differences between subtypes regarding the T-
waves, subtypes were arranged in pairs and the differences were computed. Once that was
done, the 10 nodes in which the differences were maximum were selected. The following
figures show the T-waves in those nodes after times were shifted and the T-waves laid on
top of each other.
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Fig. B.1. Each of the plot shows LQT-1 and LQT-2 waves after LQT-2 waves were shifted so that they
laid on top of each other. The node numbers correspond to the 10 nodes in which differences between
those specific subtypes were more significant.
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Fig. B.2. Each of the plot shows LQT-1 and LQT-3 waves after LQT-3 waves were shifted so that they
laid on top of each other. The node numbers correspond to the 10 nodes in which differences between
those specific subtypes were more significant.
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Fig. B.3. Each of the plot shows LQT-3 and LQT-2 waves after LQT-2 waves were shifted so that they
laid on top of each other. The node numbers correspond to the 10 nodes in which differences between
those specific subtypes were more significant.
CT-wave Analysis 2
The extracellular potentials during the T-wave were interpolated onto the thorax surface
for each of the subtypes so that a visual evaluation could be achieved. Figures C.1, C.2 and
C.3 show the 3D evolution of the voltages along the thorax, whereas figures C.4, C.5 and
C.6 show a 3D evolution but of the differences between subtypes calculated as described
in section 5.4.1. For those figures, electrodes in which the differences were significative are
also displayed to have an idea of the region where the dissimilarities are detectable.
Temporal sequences for the T-wave only (from millisecond 125 to millisecond 235) are
shown in all figures (from figure C.1 to figure C.6). The timestamps are the same in all
of them and there is a 10ms difference between each adjacent image. Slightly different
patterns can be distinguished for the three comparisons.
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Fig. C.1. LQT-1. 3D evolution representation of the simulated extracellular potentials during the T-wave
67
Fig. C.2. LQT-2. 3D evolution representation of the simulated extracellular potentials during the T-wave
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Fig. C.3. LQT-3. 3D evolution representation of the simulated extracellular potentials during the T-wave
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Fig. C.4. Substraction of LQT-2 to LQT-1. 3D evolution representation of the simulated extracellular
potentials during the T-wave
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Fig. C.5. Substraction of LQT-3 to LQT-1. 3D evolution representation of the simulated extracellular
potentials during the T-wave
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Fig. C.6. Substraction of LQT-3 to LQT-2. 3D evolution representation of the simulated extracellular
potentials during the T-wave
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